Product Information

BRIMONIDINE-TIMOLOL 0.2%-0.5% is a generic product labeled by Pacific Pharma, Inc., priced at $1.9993 per ML under NDC 82182045510. Its NADAC has been published 209 times since Nov 16, 2022.

FDA first approved this application on Oct 30, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRIMONIDINE-TIMOLOL 0.2%-0.5%

BRIMONIDINE TARTRATE, TIMOLOL MALEATE
$1.9993per ML

Strength

2; 5 mg/mL; mg/mL

NDC

82182045510

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

TOPICAL

Effective Date

10/21/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021398

FDA Approved

10/30/2007

TE Code

AB

On Market Since

10/21/2022

Pharmacological Classes

Adrenergic alpha-Agonists
Adrenergic beta-Antagonists
alpha-Adrenergic Agonist
beta-Adrenergic Blocker

Price Statistics

The NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has been published 209 times since Nov 16, 2022, and over the history we have for it it has declined 93.9%. The table below summarizes its recorded NADAC range and movement.

Current price$1.9993 per ML
All-time high$32.7869 (Nov 16, 2022)
All-time low$1.9993 (Oct 21, 2026)
52-week high$3.1134
52-week low$1.9993
Median price$9.2116
Average price$10.5713
Largest weekly change+56.9% (May 22, 2024)
Weeks tracked209
Tracking sinceNov 16, 2022

Price History

1W

0.0%

1M

-7.1%

3M

-25.3%

6M

-21.1%

1Y

-35.8%

3Y

-85.5%

5Y

N/A

All

-93.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRIMONIDINE-TIMOLOL 0.2%-0.5%?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE-TIMOLOL 0.2%-0.5%, manufactured by Pacific Pharma, Inc., is $1.9993 per ML (NDC 82182045510), effective Nov 11, 2026.

How has the price of BRIMONIDINE-TIMOLOL 0.2%-0.5% changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has declined 93.9%. It has been tracked across 209 weekly CMS publications since Nov 16, 2022.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Since Nov 16, 2022, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has ranged from a low of $1.9993 (Oct 21, 2026) to a high of $32.7869 (Nov 16, 2022), with a median of $9.2116 per ML.

Are there cheaper alternatives to BRIMONIDINE-TIMOLOL 0.2%-0.5%?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BRIMONIDINE-TIMOLOL 0.2%-0.5% in a comparable dosage form, but none are currently priced below it.

Who manufactures BRIMONIDINE-TIMOLOL 0.2%-0.5%?

BRIMONIDINE-TIMOLOL 0.2%-0.5% (NDC 82182045510) is labeled by Pacific Pharma, Inc., and CMS classifies it as a generic product.